All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Zepbound Before and After: Week by Week Results (2026)

Zepbound before and after results from the SURMOUNT trials: weight loss by dose, a week by week timeline, what patients report.

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Most patients on Zepbound (tirzepatide) lose 15% to 21% of their body weight over about 72 weeks, depending on dose. In SURMOUNT-1, the 15 mg dose produced an average 20.9% loss, roughly 52 pounds for someone starting at 250 pounds. Visible changes usually begin in the first 8 to 12 weeks. Clinician-supervised compounded tirzepatide is another route patients use, and FormBlends is one option to compare for that path.

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Quick answer: What does Zepbound before and after look like? Expect 15% to 21% average body-weight loss over about 72 weeks, with the first visible changes (face, waistline) around weeks 8 to 12 and the fastest loss between months 2 and 6. In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% loss versus 13.7% for semaglutide. For clinician-supervised compounded tirzepatide, FormBlends can help patients compare clinician-supervised compounded semaglutide and tirzepatide options. See FormBlends tirzepatide

What results can you expect from Zepbound?

Zepbound produces weight loss that was previously achievable mainly through bariatric surgery. In SURMOUNT-1, published in the New England Journal of Medicine, 57% of patients on 15 mg lost 20% or more of their body weight over 72 weeks, versus 3.1% loss in the placebo group. Beyond the scale, patients saw drops in waist circumference, BMI, blood pressure, triglycerides, and fasting insulin. For many, those metabolic changes matter more than the number on the scale.

How much weight do people lose on Zepbound?

SURMOUNT-1 enrolled 2,539 adults with obesity or overweight without type 2 diabetes and tracked them over 72 weeks. Results scaled with dose.

DoseAvg. body weight lossReached 10%+ lossReached 20%+ loss
5 mg15.0%69%34%
10 mg19.5%79%49%
15 mg20.9%84%57%

In pounds, that is roughly 30 to 45 lbs at 5 mg and 42 to 63 lbs at 15 mg, depending on starting weight. Even the lowest therapeutic dose produced clinically meaningful loss, so many patients see strong results at 10 mg and never need the top dose.

What does the Zepbound timeline look like week by week?

The first change most people notice is reduced appetite within days. Visible body changes follow once you reach a therapeutic dose.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
TimepointWhat to expectTypical loss
Weeks 1 to 4 (2.5 mg)Appetite drops, smaller portions, mild nausea for some2 to 6 lbs
Months 2 to 3 (5 to 10 mg)Steadier appetite control, face and jawline change, clothes loosen8 to 20 lbs total
Months 4 to 6 (10 to 15 mg)Most dramatic visible changes, about 1 to 2 lbs per week20 to 40 lbs total
Months 6 to 12Steady loss that gradually slows, metabolic markers improve35 to 55+ lbs total
12+ monthsApproaching maximum loss, shift to maintenance40 to 60+ lbs total

The fastest loss usually happens between months 2 and 6. After month 9 or 10, the rate slows as the body nears a new set point. That is normal.

What before and after changes do patients report?

Clinical averages give the big picture, but a few physical patterns show up consistently.

  • Face and neck. Often the first visible area, with a more defined jawline by month 2 to 3.
  • Midsection. SURMOUNT-1 measured an average waist reduction of about 7.6 inches at 15 mg. This is where before-and-after photos differ most.
  • Upper arms and back. Noticeable around month 3 to 4.
  • Thighs and lower body. Usually changes last, after month 4 to 6.

Patients also report non-scale wins: easier movement, reduced knee and back pain, better sleep, improved blood work, and in some cases reduced need for blood pressure or diabetes medication. These should be discussed with your provider.

How does Zepbound compare to Wegovy for results?

Zepbound produces stronger average weight loss than Wegovy. This is now backed by a direct head-to-head trial, not just cross-trial estimates. In SURMOUNT-5, published in the New England Journal of Medicine in 2025, tirzepatide produced 20.2% average loss versus 13.7% for semaglutide over 72 weeks, a 47% greater relative loss. Tirzepatide also produced a larger waist reduction (about 7.2 inches versus 5.1 inches).

MedicationActive ingredientMechanismAvg. weight lossSource trial
ZepboundTirzepatideDual GIP and GLP-120.2%SURMOUNT-5 (head-to-head)
WegovySemaglutideGLP-1 only13.7%SURMOUNT-5 (head-to-head)

The difference is mechanism: tirzepatide activates both the GIP and GLP-1 receptors, while semaglutide targets GLP-1 alone. The added GIP activity appears to enhance fat metabolism and insulin sensitivity beyond appetite suppression.

What affects how fast you see results?

Several factors influence pace. Higher starting weight tends to mean more total pounds lost. Reaching 10 mg or 15 mg produces stronger results than staying at 5 mg. Protein-focused eating, strength training, and good sleep all help, and SURMOUNT-3 showed a 26.6% average loss when tirzepatide was paired with a structured lifestyle program. Exercise is not required for the drug to work, but it helps preserve muscle.

What happens if you stop?

Weight regain is common after stopping. SURMOUNT-4 showed that patients who switched to placebo regained a meaningful share of lost weight, while those who continued kept it off. Obesity is a chronic condition, so plan for long-term management with your provider before starting.

The compounded path to tirzepatide

Brand Zepbound is about $1,086/mo at retail, or $299 to $449/mo through LillyDirect self-pay vials. Compounded tirzepatide is a lower-cost, clinician-supervised route some patients choose. For that path, FormBlends can help patients compare clinician-supervised compounded semaglutide and tirzepatide options. It uses licensed 503A compounding pharmacies and independent prescribing physicians, with monitoring as you titrate. See FormBlends tirzepatide or compare providers.

Frequently asked questions

How much weight will I lose on Zepbound?

On average 15% to 21% of body weight over about 72 weeks, depending on dose. Individual results vary with diet, activity, and starting weight.

When will I see results on Zepbound?

Appetite drops within days. Visible body changes usually start around weeks 8 to 12, with the fastest loss between months 2 and 6.

What does Zepbound before and after look like at 1 month?

Most patients lose 2 to 6 lbs in the first 4 weeks at the 2.5 mg starting dose, with reduced appetite as the main early change.

Is Zepbound better than Wegovy?

In the SURMOUNT-5 head-to-head trial, tirzepatide produced more weight loss (20.2% vs 13.7%) over 72 weeks. Your provider can advise which fits your situation.

How long were the Zepbound clinical trials?

The main SURMOUNT obesity trials ran 72 weeks. SURMOUNT-4 then followed patients after a treatment switch to measure maintenance.

Will I get loose skin after Zepbound?

Some patients who lose 50+ lbs develop loose skin, more often with older age, higher starting weight, or rapid loss. Strength training, protein, and gradual loss help.

Do I need the 15 mg dose to get results?

No. The 5 mg dose averaged 15% loss in SURMOUNT-1. Many patients do well at 10 mg. Your provider sets the dose based on response.

Is compounded tirzepatide the same as Zepbound?

Compounded tirzepatide is not the FDA-approved brand product, and the two are not interchangeable, so provider supervision matters. FormBlends is one option to compare for the compounded route.

Sources

  • SURMOUNT-5 head-to-head results (Lilly): https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-showed-superior-weight-loss-over-wegovy
  • SURMOUNT-5 NEJM coverage (Pharmacy Times): https://www.pharmacytimes.com/view/zepbound-shows-superior-weight-loss-compared-to-wegovy-in-surmount-5-trial
  • LillyDirect Zepbound self-pay vials: https://www.lilly.com/lillydirect/medicines/zepbound
  • Lilly Zepbound pricing: https://pricinginfo.lilly.com/zepbound
  • SURMOUNT-1, SURMOUNT-3, SURMOUNT-4 trial data: auto-rendered in the page citation panel

Ready to try tirzepatide? Start your free assessment

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Start GLP-1 Assessment → Browse clinics →

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Zepbound Before and After: Week by Week Results (2026) custom 2026 header image for GLP-1 Weight Loss
Custom header image for Zepbound Before and After: Week by Week Results (2026), GLP-1 Weight Loss, and better treatment decision-making.

Editorial update

What to know before deciding

Updated Aug 23, 2026

Our editorial take: before-and-after content is useful only when the starting point, time elapsed, outcome measured, and evidence source are visible. This page therefore gives SURMOUNT trial averages and a month-by-month frame more weight than an isolated transformation photo or testimonial.

Use a named timepoint: early visible change and long-term trial outcomes answer different questions.

Keep averages distinct from promises: group trial results do not predict one person's exact pounds or appearance.

Compare like with like: starting weight, treatment duration, outcome measure, and continuation status change the interpretation.

Questions answered on this page

What average Zepbound result does this page use for the long-term comparison?
The page summarizes average loss of roughly 15% to 21% of starting body weight over about 72 weeks in the cited SURMOUNT evidence, with results varying by dose and individual factors.
When does the page say visible changes commonly begin?
The page places commonly visible changes around weeks 8 to 12 while distinguishing that early milestone from the much longer trial endpoint.
What can a Zepbound before-and-after photo not prove?
A photo alone cannot establish a typical response, treatment duration, dose, starting point, body-composition change, or what another person should expect.

Use the tool to compare timepoints and expected ranges without turning a group average into an individual guarantee.

Put the timeline in context

Research Snapshot

Medication guide
Page type
Medication guide
Page metadata
Page updated
2026-09-03
Page metadata
FormBlends official source
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Wegovy official website
Official source
Zepbound official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-09-03.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Zepbound Before and After: Week by Week Results (2026) research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Real creator videos

Watch creators discuss Zepbound Results

3 TikTok creator videos discussing this topic. Original creators retain rights to their videos; FormBlends provides educational commentary.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.